Similar companies
Did Haemonetics Corporation Beat Earnings?
Haemonetics Corporation (HAE) reported Q2 '26 revenue of $339M, up 5.6% year-over-year, with reported EPS of $1.14. That topped the $1.07 analyst estimate by 6.5% — an earnings beat.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Haemonetics Corporation’s job postings, web traffic, and employee business outlook. See the full HAE stock analysis or the earnings calendar for upcoming reports.
HAE Earnings Surprise History (EPS vs. Estimate)
| Quarter | Estimated EPS | Reported EPS | Surprise |
|---|---|---|---|
| Q2 '26 | $1.07 | $1.14 | Beat +6.5% |
| Q1 '26 | $1.27 | $1.29 | Beat +1.6% |
| Q4 '25 | $1.25 | $1.31 | Beat +4.8% |
| Q3 '25 | $1.11 | $1.27 | Beat +14.4% |
| Q2 '25 | $1.01 | $1.10 | Beat +8.9% |
| Q1 '25 | $1.22 | $1.24 | Beat +1.6% |
Haemonetics Corporation Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 346M | 349M | 331M | 321M | 327M | 339M | 346M | 339M |
| Gross margin | 55.3% | 57.4% | 55.0% | 59.7% | 56.0% | 56.5% | 57.2% | 59.8% |
| Operating margin | 15.0% | 16.9% | 15.6% | 16.8% | 20.6% | 20.5% | 14.9% | 16.9% |
| Net income | 34M | 37M | 58M | 34M | 39M | 45M | -20M | 33M |
| Net margin | 9.8% | 10.8% | 17.5% | 10.6% | 11.8% | 13.2% | -5.8% | 9.7% |
| EPS | $1.12 | $1.19 | $1.24 | $1.10 | $1.27 | $1.31 | $1.29 | $1.14 |
Haemonetics Corporation Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Haemonetics Corporation’s quarterly revenue moved from $346M to $339M. Net margin held roughly steady from 9.8% to 9.7%, against a 59.8% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Haemonetics Corporation has beaten Wall Street EPS estimates in 8 of its last 8 reported quarters.
When Is Haemonetics Corporation’s Next Earnings Date?
Haemonetics Corporation reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the HAE earnings calendar.
Frequently Asked Questions: Haemonetics Corporation Earnings
Haemonetics Corporation's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Haemonetics Corporation reported Q2 '26 EPS of $1.14 on revenue of $339M (+5.6% YoY). Haemonetics Corporation beat estimates, reporting $1.14 vs. the $1.07 estimate.
Haemonetics Corporation reported Q2 '26 revenue of $339M, up 5.6% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the HAE AI Score.
